These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25016699)

  • 1. The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome.
    Allal-Elasmi M; Zayani Y; Zidi W; Zaroui A; Feki M; Mourali S; Mechmeche R; Kaabachi N
    Clin Lab; 2014; 60(6):951-6. PubMed ID: 25016699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
    Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Zaroui A; Feki M; Mourali S; Mechmech R; Kaabachi N
    Clin Lab; 2013; 59(1-2):169-75. PubMed ID: 23505923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
    Chen N; Zhang JY; Yang SZ; Li YD
    J Biol Regul Homeost Agents; 2015; 29(2):437-41. PubMed ID: 26122234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
    Giansante C; Fiotti N; Di Chiara A; Altamura N; Wasserman S; Fioretti P; Guarnieri G
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):602-7. PubMed ID: 17667031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence.
    Pussinen PJ; Sarna S; Puolakkainen M; Öhlin H; Sorsa T; Pesonen E
    Int J Cardiol; 2013 Jul; 167(2):362-8. PubMed ID: 22257687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
    Derosa G; D'Angelo A; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; Cicero AF
    Heart Vessels; 2007 Nov; 22(6):361-70. PubMed ID: 18043992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor [corrected] of matrix metalloproteinase-1 in myocardial infarction.
    Guzel S; Serin O; Guzel EC; Buyuk B; Yılmaz G; Güvenen G
    Korean J Intern Med; 2013 Mar; 28(2):165-73. PubMed ID: 23525523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.
    Cheng M; Hashmi S; Mao X; Zeng QT
    Can J Cardiol; 2008 May; 24(5):385-90. PubMed ID: 18464944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
    Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome.
    Parkkonen O; Nieminen MT; Vesterinen P; Tervahartiala T; Perola M; Salomaa V; Jousilahti P; Sorsa T; Pussinen PJ; Sinisalo J
    PLoS One; 2017; 12(3):e0173371. PubMed ID: 28278213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of serum neutrophil markers and acute coronary syndrome.
    Alfakry H; Sinisalo J; Paju S; Nieminen MS; Valtonen V; Tervahartiala T; Pussinen PJ; Sorsa T
    Scand J Immunol; 2012 Aug; 76(2):181-7. PubMed ID: 22537345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of atherosclerotic plaque stability and inflammation in the pathogenesis of acute coronary syndrome].
    Ding SF; Zhang Y; Zhang M; Chen WQ; Chen YG; Li JF; Ji QS; Li GS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):512-4. PubMed ID: 16842667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
    Inokubo Y; Hanada H; Ishizaka H; Fukushi T; Kamada T; Okumura K
    Am Heart J; 2001 Feb; 141(2):211-7. PubMed ID: 11174334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.
    Dabek J; Glogowska-Ligus J; Szadorska B
    J Postgrad Med; 2013; 59(2):115-20. PubMed ID: 23793312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.
    Tedeschi A; Asero R; Lorini M; Marzano AV; Cugno M
    Clin Exp Allergy; 2010 Jun; 40(6):875-81. PubMed ID: 20214668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.
    Hoseini SM; Kalantari A; Afarideh M; Noshad S; Behdadnia A; Nakhjavani M; Esteghamati A
    Metabolism; 2015 Apr; 64(4):527-38. PubMed ID: 25633268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.
    Tan J; Hua Q; Gao J; Fan ZX
    Clin Cardiol; 2008 Sep; 31(9):413-8. PubMed ID: 18781600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.